Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
PT Ciputra Development Tbk (CTRA.JK)
Jakarta, ID
PT Ciputra Development Tbk, an Indonesian real estate conglomerate operating with its various subsidiaries, is engaged in the construction and marketing of properties across Indonesia. The company's business activities are broadly divided into its residential and commercial property divisions. Its residential developments encompass a range of offerings including land parcels, individual homes, mixed-use shophouses, apartment complexes, and individually owned office units. In its commercial segment, the company develops and manages projects such as shopping centers (which it also leases out), hotels, healthcare facilities, golf courses, and water parks. Established in 1981 and headquartered in Jakarta, Indonesia, the firm was originally named PT Citra Habitat Indonesia before officially adopting its current name, PT Ciputra Development Tbk, in December 1990. The company operates as a subsidiary of PT Sang Pelopor.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -0.72% | -6.80% | -18.45% | -20.35% | -16.97% | -32.84% | -39.11% | -38.01% | -44.64% | +770.95% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 7 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Real Estate - Development: +7.6%+21.0% ★ Q1'26: -4.3% (vs Q1'25)
-
EPS growth Real Estate - Development: +14.9%+15.2% ★ Q1'26: -21.5% (vs Q1'25)
-
FCF margin Real Estate - Development: +13.4%+13.0% Q1'26: -6.1% (vs Q1'25)
-
EBIT margin Real Estate - Development: +18.2%+26.5% ★ Q1'26: +28.9% (vs Q1'25)
-
ROIC Real Estate - Development: +3.4%+12.9% ★ Q1'26: +11.1% (vs Q1'25)
-
Share dilution Real Estate - Development: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Real Estate - Development: 1.28×2.55× Q1'26: 2.30× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 7 Rev. Ana. 5 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
7.51T
est: 7.66T (-1.9%)
|
6.74T
est: 6.59T (+2.2%)
|
6.44T
est: 6.85T (-6.0%)
|
7.67T
est: 7.55T (+1.6%)
|
7.61T
est: 7.19T (+5.8%)
|
8.07T
est: 6.89T (+17.1%)
|
9.73T
est: 8.89T (+9.4%)
|
9.13T
est: 9.32T (-2.1%)
|
9.25T
est: 9.81T (-5.8%)
|
11.19T
est: 10.20T (+9.7%)
|
12.67T
est: 12.06T (+5.0%)
|
12.03T
11.51T – 12.56T
-0.2% YoY
|
12.10T
10.20T – 13.82T
+0.5% YoY
|
13.03T
13.03T – 13.03T
+7.7% YoY
|
| EBITDA |
2.75T
est: 2.69T (+2.4%)
|
2.19T
est: 2.32T (-5.6%)
|
1.95T
est: 2.41T (-19.1%)
|
2.46T
est: 2.65T (-7.0%)
|
2.36T
est: 2.52T (-6.4%)
|
2.80T
est: 2.42T (+15.7%)
|
3.78T
est: 3.12T (+21.2%)
|
3.52T
est: 3.27T (+7.5%)
|
3.29T
est: 3.44T (-4.4%)
|
3.12T
est: 3.57T (-12.7%)
|
4.34T
est: 4.23T (+2.8%)
|
4.22T
4.03T – 4.40T
-0.2% YoY
|
4.24T
3.57T – 4.84T
+0.5% YoY
|
4.56T
4.56T – 4.56T
+7.7% YoY
|
| EBIT |
2.65T
est: -676.01B (+492.2%)
|
2.07T
est: -582.19B (+455.0%)
|
1.84T
est: -604.75B (+404.9%)
|
2.33T
est: -666.18B (+450.0%)
|
2.23T
est: -634.59B (+451.0%)
|
2.66T
est: -608.23B (+537.8%)
|
3.36T
est: -785.03B (+527.8%)
|
3.38T
est: -822.68B (+510.6%)
|
2.93T
est: 489.98B (+498.6%)
|
2.96T
est: 509.12B (+481.9%)
|
3.93T
est: 602.22B (+553.1%)
|
600.75B
574.51B – 626.98B
-0.2% YoY
|
603.94B
509.30B – 690.11B
+0.5% YoY
|
650.57B
650.57B – 650.57B
+7.7% YoY
|
| Net Income |
1.28T
est: 1.57T (-18.4%)
|
861.76B
est: 1.03T (-16.4%)
|
894.35B
est: 967.13B (-7.5%)
|
1.19T
est: 1.08T (+9.8%)
|
1.16T
est: 981.28B (+18.0%)
|
1.32T
est: 802.94B (+64.5%)
|
1.74T
est: 1.50T (+15.7%)
|
1.86T
est: 1.84T (+1.3%)
|
1.85T
est: 2.10T (-11.9%)
|
2.13T
est: 2.00T (+6.4%)
|
2.66T
est: 2.52T (+5.6%)
|
2.44T
2.32T – 2.46T
-3.2% YoY
|
2.40T
1.89T – 2.71T
-1.6% YoY
|
2.59T
2.35T – 2.91T
+8.0% YoY
|
| SGA |
651.91B
est: 540.73B (+20.6%)
|
667.27B
est: 465.68B (+43.3%)
|
644.31B
est: 483.73B (+33.2%)
|
655.98B
est: 532.86B (+23.1%)
|
683.96B
est: 507.60B (+34.7%)
|
596.08B
est: 486.51B (+22.5%)
|
609.96B
est: 627.93B (-2.9%)
|
652.58B
est: 658.05B (-0.8%)
|
679.41B
est: 547.96B (+24.0%)
|
800.19B
est: 569.37B (+40.5%)
|
—
est: 673.50B (-100.0%)
|
671.85B
642.51B – 701.18B
-0.2% YoY
|
675.42B
569.57B – 771.78B
+0.5% YoY
|
727.56B
727.56B – 727.56B
+7.7% YoY
|
| EPS |
84.00
est: 84.86 (-1.0%)
|
55.00
est: 55.60 (-1.1%)
|
48.00
est: 52.18 (-8.0%)
|
63.96
est: 58.27 (+9.8%)
|
62.47
est: 52.94 (+18.0%)
|
71.25
est: 43.32 (+64.5%)
|
93.62
est: 80.92 (+15.7%)
|
100.53
est: 99.16 (+1.4%)
|
99.60
est: 113.10 (-11.9%)
|
114.71
est: 108.25 (+6.0%)
|
143.67
est: 126.69 (+13.4%)
|
128.90
125.32 – 132.48
+1.7% YoY
|
131.00
102.14 – 146.02
+1.6% YoY
|
139.93
126.70 – 157.08
+6.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | A+ | 5/5 | 5/5 | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-11 | A+ | 5/5 | 5/5 | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-08 | A+ | 5/5 | 5/5 | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-07 | A+ | 5/5 | 5/5 | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-06 | A+ | 5/5 | 5/5 | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-05 | A+ | 5/5 | 5/5 | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-04 | A+ | 5/5 | 5/5 | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-04-30 | A+ | 5/5 | 5/5 | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-04-29 | A+ | 5/5 | 5/5 | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-04-28 | A+ | 5/5 | 5/5 | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-04-27 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-24 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-23 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-22 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-21 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-20 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-17 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-16 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-15 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-14 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-13 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-10 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Agussurja Widjaja | Director of Operation & Director | — | — |
| Artadinata Djangkar | Director of Operation & Director | — | male |
| Budiarsa Sastrawinata | MD of Div. 1 & Director | — | male |
| Cakra Ciputra | MD of Div. 3 & Director | — | male |
| Candra Ciputra | President Director | — | male |
| Fadjar Halim | Internal Audit Division Head | — | male |
| Harun Hajadi | MD of Div. 2 & Director | — | male |
| Marius Ignatius Meiko Handoyo Lukmantara | Director of Operation & Director | — | male |
| Nanik Joeliawati Santoso | Director of Operation & Director | — | female |
| Sutoto Yakobus | Director of Operation & Director | — | — |
| Tulus Santoso Brotosiswojo | Company Secretary & Independent Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CTRA.JK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
